Paclitaxel (Taxol) Description
Paclitaxel (Taxol) is extracted from Taxaceae. Stanford Advanced Materials has been providing quality Paclitaxel (Taxol) and many other natural plant extracts for over 15 years.
Paclitaxel (Taxol) Specification
Product Name
|
Paclitaxel (Taxol)
|
CAS No.
|
33069-62-4
|
Molecular Formula
|
C47H51NO14 |
Molecular Weight
|
853.91
|
Botanical Source
|
Taxaceae |
Purity
|
98% HPLC
|
Appearance
|
White powder
|
Package
|
25 kg/drum
|
Storage
|
Stored in cool & dry places, away from direct sunlight and heat.
|
Shelf Life
|
2 years
|
Paclitaxel (Taxol) Application:
Breast Cancer: Paclitaxel is commonly used in the treatment of advanced breast cancer, where it has been shown to improve survival rates. It is often administered after failure of initial chemotherapy or as part of a combination therapy.
Ovarian Cancer: It's used as a first-line treatment for advanced ovarian cancer and in cases where other treatments have failed. Paclitaxel, combined with platinum-based compounds like cisplatin or carboplatin, has significantly improved treatment outcomes.
Lung Cancer: In non-small cell lung cancer (NSCLC), paclitaxel is used as a part of combination chemotherapy, showing benefits in overall survival and quality of life for patients.
AIDS-related Kaposi's Sarcoma: Paclitaxel has been effective in treating Kaposi's sarcoma in patients with AIDS, showing significant tumor shrinkage in many cases.
Pancreatic Cancer: While pancreatic cancer is notoriously difficult to treat, paclitaxel (especially in its nanoparticle albumin-bound form) is used to improve outcomes in metastatic pancreatic cancer, often in combination with other drugs.
Head and Neck Cancer: It is used in the treatment of advanced head and neck cancer, usually in combination with other chemotherapeutic agents.
Cervical Cancer: Paclitaxel is used in advanced cervical cancer treatments, often combined with cisplatin and radiation therapy, showing improved survival rates.
Gastric Cancer: For advanced gastric cancer, paclitaxel has been used both as a single agent and in combination with other chemotherapy drugs to improve response rates and survival.